Lexicon Pharmaceuticals, Inc.

NasdaqGS:LXRX Stock Report

Market Cap: US$831.4m

Lexicon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:LXRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Nov 23BuyUS$94,797Lonnel CoatsIndividual90,000US$1.05
13 Nov 23BuyUS$201,520Philippe AmouyalIndividual200,000US$1.01
10 Nov 23BuyUS$10,100Lonnel CoatsIndividual10,000US$1.01
12 Oct 23BuyUS$1,103,957Raymond DebbaneIndividual1,000,000US$1.14
14 Sep 23BuyUS$13,800Jeffrey WadeIndividual10,000US$1.38
04 Aug 23BuyUS$11,040Wendy McDermottIndividual6,000US$1.84

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of LXRX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,250,1981.18%
Institutions89,982,99824.9%
General Public92,159,71525.5%
VC/PE Firms175,099,38448.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.9%.


Top Shareholders

Top 25 shareholders own 72.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
48.4%
Artal Group S.A.
175,099,384US$402.7m49%10.08%
10.7%
FMR LLC
38,687,123US$89.0m178%0.01%
2.13%
BlackRock, Inc.
7,693,277US$17.7m9.82%no data
1.77%
The Vanguard Group, Inc.
6,401,225US$14.7m7.04%no data
1.51%
The Invus Group, LLC
5,451,204US$12.5m0%35.62%
0.98%
OrbiMed Advisors LLC
3,542,000US$8.1m0%0.12%
0.9%
Medical Strategy GmbH, Asset Management Arm
3,253,535US$7.5m0%0.42%
0.66%
Geode Capital Management, LLC
2,389,137US$5.5m1.71%no data
0.66%
New Enterprise Associates, Inc.
2,382,286US$5.5m0%0.33%
0.55%
Point72 Asset Management, L.P.
1,989,314US$4.6m0%0.01%
0.55%
State Street Global Advisors, Inc.
1,987,510US$4.6m5.03%no data
0.48%
Pinnacle Associates, Ltd.
1,747,830US$4.0m0.98%0.06%
0.47%
BVF Partners L.P.
1,686,924US$3.9m-93.1%0.1%
0.39%
Columbia Management Investment Advisers, LLC
1,417,950US$3.3m-25%no data
0.37%
Raymond Debbane
1,348,879US$3.1m0.6%no data
0.3%
Lonnel Coats
1,098,068US$2.5m20.1%no data
0.27%
Schonfeld Strategic Advisors LLC
960,150US$2.2m0%0.02%
0.24%
Charles Schwab Investment Management, Inc.
881,123US$2.0m0%no data
0.24%
Northern Trust Global Investments
866,556US$2.0m0.81%no data
0.19%
Wellington Management Group LLP
686,418US$1.6m0%no data
0.15%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
549,367US$1.3m26%no data
0.15%
Hennion & Walsh Asset Management, Inc.
542,899US$1.2m0%0.07%
0.15%
Millennium Management LLC
534,184US$1.2m-67.3%no data
0.14%
Marshall Wace LLP
499,172US$1.1m0%no data
0.11%
Caspar Towarzystwo Funduszy Inwestycyjnych S.A.
401,300US$923.0k0%4.27%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.